Clinical Trials Browser

Leukemia, Promyelocytic, Acute

Carcinoma, Hepatocellular

Cytokine Release Syndrome, Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms

Colonic Neoplasms

Disease, Pancreatic Neoplasms

Neoplasms, Pain

Gallbladder Neoplasms

Leukemia, Myeloid, Acute

Immunotherapy Gastrict Cancer

Esophageal Squamous Cell Carcinoma

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

Prostatic Neoplasms

Infertility, Polycystic Ovary Syndrome

Hydatidiform Mole, Gestational Trophoblastic Disease

Carcinoma, Hepatocellular

Rectal Neoplasms

Breast Neoplasms, Neoplasms

Carcinoma, Ovarian Epithelial

Polycystic Ovary Syndrome

Insulin Resistance, Prostatic Neoplasms

Advanced Solid Tumor

Esophageal Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Rectal Neoplasms

Breast Neoplasms

Thyroid Neoplasms

Oesophagogastric Cancer

Breast Neoplasms, Leukopenia

Osteosarcoma

Lung Neoplasms, Weight Loss

Clinical Trials

Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

BIIRTH

NexCAR19

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Colon Cancer Diagnosis With FAPI-PET Imaging

Pancreatic Cancer Diagnosis With FAPI-PET Imaging

Improving Pain Management in Hospitalized Cancer Patients. A Before-after Cluster Phase II Trial

POLCAGB

BIG-1

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 Vs Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression

STAMPEDE

Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

TACE-SBRT

Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.

Triple Antigen vs Monoantigen Immunotherapy for Warts

ELSA

Primary Progesterone Therapy for Operable Breast Cancer

Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer

Empagliflozin vs Metformin in PCOS

Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)

Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody

SCOPE2

Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

INCAGI004

INNOVBC

Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer

ST03

Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy

DOTAGLI

ZOL

Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer